banner add

It Was a Promising Addiction Treatment. Many Patients Never Got It.

How political red tape and a drug company’s thirst for profits limited the reach of a drug that experts believe could have reduced the opioid epidemic’s toll.

from NYT > Health https://ift.tt/rcKJMgO
via IFTTT

No comments

Buildings May Soon Have ‘Immune Systems’ That Fight Airborne Disease

Following the pandemic, the federal government is spending $150 million on new technology to ensure clean indoor air. Here’s what scientists...

Theme images by PLAINVIEW. Powered by Blogger.